Gielen E, Aldven M, Kanis JA, Borgstrom F, et al. Cost-effectiveness of romosozumab for the treatment of postmenopausal women with osteoporosis at high risk of fracture in Belgium. Osteoporos Int 2024 Apr 2. doi: 10.1007/s00198-024-07043.
PMID: 38565690